McCourt Marion's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed Dec 14, 2021
- Accession no.
- 0001883850-21-000030
- Filed
- Dec 14, 2021
- Trade date
- Dec 11-13, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $224.7K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McCourt MarionCIK 0001663758 | Officer (EVP Commercial) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2021 | Common Stock | FTax withholdingDisposed | −388 | $664.34 | −$257,763.92 | 19,988 | Direct | |
| Dec 13, 2021 | Common Stock | SSaleDisposed | −344 | $653.12 | −$224,673.28 | 19,644 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.